A detailed history of Schechter Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 7,232 shares of AMGN stock, worth $2.29 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
7,232
Previous 6,837 5.78%
Holding current value
$2.29 Million
Previous $1.94 Million 16.26%
% of portfolio
0.23%
Previous 0.19%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $103,786 - $126,127
395 Added 5.78%
7,232 $2.26 Million
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $100,288 - $121,060
-373 Reduced 5.17%
6,837 $1.94 Million
Q4 2023

Jan 17, 2024

SELL
$255.7 - $288.46 $48,583 - $54,807
-190 Reduced 2.57%
7,210 $2.08 Million
Q3 2023

Nov 06, 2023

BUY
$218.65 - $271.46 $347,216 - $431,078
1,588 Added 27.32%
7,400 $1.99 Million
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $206,770 - $244,502
-965 Reduced 14.24%
5,812 $1.29 Million
Q1 2023

Apr 28, 2023

BUY
$225.79 - $275.2 $422,001 - $514,348
1,869 Added 38.08%
6,777 $1.64 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $57,028 - $72,461
249 Added 5.34%
4,908 $1.29 Million
Q3 2022

Nov 04, 2022

SELL
$224.46 - $253.15 $62,848 - $70,882
-280 Reduced 5.67%
4,659 $1.05 Million
Q2 2022

Nov 03, 2022

BUY
$230.71 - $256.74 $1.14 Million - $1.27 Million
4,939 New
4,939 $1.2 Million
Q1 2022

Nov 18, 2022

SELL
$219.27 - $242.57 $42,099 - $46,573
-192 Reduced 4.12%
4,467 $1.08 Million
Q4 2021

Dec 27, 2022

SELL
$198.88 - $227.6 $136,232 - $155,906
-685 Reduced 14.7%
3,974 $894,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.